Trial reportDrug design, development and therapy2026
Liposomal Bupivacaine for Adductor Canal Block Combined with IPACK Block in Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Trial.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07509866 (A Randomized Trial of Liposomal Bupivacaine, Ropivacaine With Perineural Dexamethasone, and Ropivacaine With Perineural Dexmedetomidine for Adductor Canal Block Combined With IPACK Block in Total Knee Arthroplasty), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Trial of Liposomal Bupivacaine, Ropivacaine With Perineural Dexamethasone, and Ropivacaine With Perineural Dexmedetomidine for Adductor Canal Block Combined With IPACK Block in Total Knee Arthroplasty
Who cites it
3 citing papers in PubMed.
- Liposomal bupivacaine versus ropivacaine in four-in-one nerve block for total knee arthroplasty: a randomized controlled trial.BMC anesthesiology · 2026Trial
- Liposomal bupivacaine in peri-articular injection reduces opioid consumption and improves early prognosis of total knee arthroplasty: a randomized controlled trial.BMC musculoskeletal disorders · 2026Trial
- Liposomal Bupivacaine in Perioperative Analgesia: A Comprehensive Review of Clinical Efficacy, Safety, and Economic Context.Current pain and headache reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Patients undergoing total knee arthroplasty (TKA) may experience severe postoperative pain despite preoperative nerve blocks. This study aims to investigate the effect of liposomal bupivacaine (LB) for adductor canal block (ACB) combined with infiltration between the popliteal artery and the posterior knee capsule (iPACK) in TKA. Patients and Methods: This prospective, double-blind, randomized controlled trial was conducted from March 2025 to August 2025 in a Chinese tertiary hospital. 86 patients aged 18-90 years, classified as the American Society of Anesthesiologists (ASA) Physical Status I-III and undergoing TKA, were randomly assigned to either the liposomal bupivacaine group (Group LB) or ropivacaine group (Group R). All patients underwent ACB combined with iPACK block administered with either LB or ropivacaine preoperatively. The primary outcome was visual analog scale (VAS) at multiple time points under three conditions: at rest, during maximum knee flexion, and during ambulation. Secondary outcomes included opioids consumption, knee range of motion (ROM), quadriceps strength, the Timed Up-and-Go (TUG) test within the first 3 days, as well as the American Knee Society (AKS) score and the Quality of Recovery-15 (QoR-15) score assessed at 2 weeks and 1 month. Results: Demographic and baseline characteristics were comparable between groups (P>0.05). The VAS scores in Group LB were significantly lower than those in Group R at 24h, 48h, and 72h across all assessment conditions ( Conclusion: Liposomal Bupivacaine for adductor canal block combined with IPACK block provided no clinically significant benefit in patients undergoing total knee arthroplasty.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.